Bluejay Diagnostics (BJDX) Debt Ratio (2020 - 2021)
Bluejay Diagnostics (BJDX) posted Debt Ratio of 0.0 for Q4 2021, down 98.35% sequentially from 0.03 in Q3 2021, and down 99.31% YoY from 0.08 in Q4 2020.
Bluejay Diagnostics (BJDX) Debt Ratio (2020 - 2021) Analysis & Trends
Bluejay Diagnostics has reported Debt Ratio for 2 years, with the latest figure at 0.0 in Q4 2021.
- Quarterly Debt Ratio fell 99.31% year-over-year to 0.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was 0.0 (down 99.31% YoY) and the FY2021 annual result came in at 0.0, down 99.31% from the prior year.
- Debt Ratio declined to 0.0 in Q4 2021 per BJDX's latest filing, from 0.03 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.08 in Q4 2020 and troughed at 0.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.62 Bn | 197.02 Bn | 7.27 Bn | 0.30 |
| 2 | Stryker | 126.48 Bn | 123.00 Bn | 4.50 Bn | 0.31 |
| 3 | Medtronic | 119.39 Bn | 110.17 Bn | 6.41 Bn | 0.30 |
| 4 | Boston Scientific | 74.22 Bn | 73.68 Bn | 3.85 Bn | 0.28 |
| 5 | Edwards Lifesciences | 51.61 Bn | 47.35 Bn | 1.35 Bn | 0.04 |
| 6 | Dexcom | 34.96 Bn | 33.02 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.73 Bn | 31.62 Bn | 2.18 Bn | 0.27 |
| 8 | Koninklijke Philips | 26.21 Bn | 22.89 Bn | 4.55 Bn | 0.28 |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 0.18 |
| 10 | Bluejay Diagnostics | 1.93 Mn | 1.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.03 |
| Dec 31, 2020 | 0.08 |